摘要
目的探讨心理干预对新确诊HIV/AIDS患者接受抗病毒治疗意愿的影响。方法随机抽取2014年12月30日—2018年12月30日在我中心新确诊的HIV/AIDS患者240例作为研究对象,采用随机数表法分为实验组和对照组各120例,实验组实施心理干预,对照组实施常规护理干预,对比2组患者干预前后心理健康变化及抗病毒治疗意愿。结果新确诊HIV/AIDS患者抑郁发生率为59.58%,焦虑发生率为59.17%;干预后,2组患者抑郁自评量表(self-rating depressionscale,SDS)、焦虑自评量表(self-rating anxiety scale,SAS)得分和抑郁、焦虑发生率均比干预前显著降低(P均<0.05),且干预后实验组SDS、SAS得分和抑郁、焦虑发生率均显著低于对照组(P均<0.05);干预后,实验组接受抗病毒治疗人数比例(97.5%)显著高于对照组(85.0%),差异有统计学意义(χ^2=11.742,P=0.001)。结论心理干预能提高新确诊HIV/AIDS患者抗病毒治疗的意愿,值得临床采纳推广。
Objective To investigate the effect of psychological intervention on the receiving antiviral therapy intention of newly diagnosed HIV/AIDS patients.Methods Two hundred and forty newly diagnosed HIV positive patients were randomly selected from December 30,2014 to December 30,2018 in our hospital.They were randomly divided into experimental group and control group,with 120 cases in each group.The experimental group was given psychological intervention,while the control group was given routine nursing intervention.The changes of mental health and the willingness of receiving antiviral therapy in 2 groups were compared before and after intervention.Results The incidences of depression and anxiety in newly diagnosed HIV/AIDS patients were 59.58%and 59.17%respectively.After intervention,the self-rating depression scale(SDS)scores,the self-rating anxiety scale(SAS)scores,and the incidences of depression and anxiety in the 2 groups were significantly lower than those before intervention(P<0.05).SDS scores,SAS scores and the incidences of depression and anxiety in the experimental group were significantly lower than those in the control group(P<0.05).After intervention,the percentage of patients receiving antiviral treatment in the experimental group(97.5%)was significantly higher than that in the control group(85.0%).The difference was statistically significant(χ^2=11.742,P=0.001).Conclusions Psychological intervention can increase the number of newly diagnosed HIV/AIDS infected patients receiving antiviral therapy,which is worthy of clinical promotion.
作者
宋兵
赵壮红
秦玉玲
黄辉煌
周雨婷
张恩凤
许洪新
姜天俊
SONG Bing;ZHAO Zhuang-hong;QIN Yu-ling;HUANG Hui-huang;ZHOU Yu-ting;ZHANG En-feng;XU Hong-xin;JIANG Tian-jun(Treatment and Research Center for Infectious Diseases,the Fifth Medical Center of Chinese PLA General Hospital,Beijing 100039,China)
出处
《传染病信息》
2019年第4期366-368,共3页
Infectious Disease Information
基金
“十三五”国家科技重大专项(2017ZX10202101-005-001)